Oncology News

Breast Cancer Awareness Poster – CoC

Posted by on September 25, 2016 at 7:14 pm

Warning: Illegal offset type in isset or empty in /home3/mwebb/public_html/wp-content/plugins/winnr/model/excerptHandler.php on line 138

If you are a CoC-accredited facility a free Breast Cancer Awareness Poster is available to your organization for the month of October.  This year’s poster was announced in the CoC newsletter is stunningly simple and beautiful and available for immediate download.  There are any number of ways you can use the poster, consider: Hospital Employees and Staff […]

Keeping Up with Seismic Growth in Genetic Testing

Posted by on September 23, 2016 at 8:28 am

Warning: Illegal offset type in isset or empty in /home3/mwebb/public_html/wp-content/plugins/winnr/model/excerptHandler.php on line 138

There has been a seismic increase in the number of laboratories and genetic tests and studies since 2013, due in part to the Supreme Court ruling that human genes are not patentable.  More and more labs are offering testing and multigene panels, new genes and gene mutations are being identified each and every day.  While […]

Why Eric Stonestreet Advocates for Cancer

Posted by on July 14, 2016 at 8:14 pm

Warning: Illegal offset type in isset or empty in /home3/mwebb/public_html/wp-content/plugins/winnr/model/excerptHandler.php on line 138

I love Eric Stonestreet as an actor but when I saw this video I was so impressed!  He’s riding high in Hollywood and yet has not forgotten the cancer patient in the process.  

New Drug for Mantle Cell Lymphoma

Posted by on November 6, 2015 at 7:44 am

Warning: Illegal offset type in isset or empty in /home3/mwebb/public_html/wp-content/plugins/winnr/model/excerptHandler.php on line 138

A new combination treatment eliminating many of the side effects of traditional chemotherapy for mantle cell lymphoma has shown favorable response in a two-year trial according to Weill Cornell Medicine research.  The pill Lenalidomide, taken in combination with the antibody Rituximab shrunk tumor size by more than more than half in 90% of the patients enrolled […]